6 Sell Rated Technology Stocks by Goldman Sachs

Goldman Sachs published a report entitled “Americas: Technology: IT Services” on January 11, 2012. The report isn’t publicly available but we will discuss its main points. In their report, Julio C. Quinteros Jr., Vincent Lin, Roman Leal, and Geo John are defensive for the IT services sector in the year 2012. Goldman Sachs (GS) is concerned about the “current macro backdrop, with expectations for a slower global growth clouding visibility as we head onto 2012”. They have concentrated on stocks that are U.S. based mentioning a number of buy and sell rated stocks. Here are Goldman Sachs’ sell rated stocks.

Goldman Sachs Group Inc (NYSE:GS)

Computer Sciences Corporation (CSC) provides information technology and professional services to both the government and commercial enterprises. Goldman Sachs has given the company a sell rating and remains cautious on its valuation. Computer Sciences Corporation has significant exposure to the Department of Defense which is looking to cut budget in 2012. Also, Goldman Sachs is of the opinion that due to Computer Sciences Corporation’s sluggish booking and a potential loss of the NHS contract, its shares are going to be impacted negatively. Shares of the company are currently trading at $24.9 per share and are expected to go south of $22 by the end of 2012. Glenview Capital sold its entire $42 million position in CSC during the third quarter.

CSG Systems International, Inc. (CSGS) provides outsourced customer care and billing solutions for North America. It has been given a sell rating by Goldman Sachs due to its exposure to the U.S. cable/satellite vertical services. CSG Systems also has a long sales cycle of transformation software deals that are resulting in headwinds. With a lower expected demand for ancillary services in the company’s core processing business, its valuation will most likely be negatively impacted. Shares of the company are currently trading at $15.7 per share and are expected to go south of $13. Currently, it has a price-to-earnings ratio of 18x. Intrepid Capital Management had $26 million in CSGS at the end of September.

Convergys Corporation (CVG) provides relationship management solutions on a global basis and operates in both the Customer Management and Information Management sectors. Goldman Sachs has given the company a sell rating because it believes that Convergys is a low growth company with lower returns to scale. Goldman Sachs recently increased its expected target price due to a higher implied CY2012 price-to-earnings ratio of 12x versus the earlier estimate of 10.9x. This is based on an improvement in the company’s growth prospects with regards to volume. Convergys also recently announced that it is going to buy back shares. Its shares are currently trading at $12.8 per share and are expected to fall to a price target of $11. Barry Rosenstein sold 41% of his stake in CVG during the third quarter.

Equifax, Inc. (EFX) collects, organizes, and manages various financial, demographic, employment, and marketing information solutions for businesses and consumers. Goldman Sachs has given the company a sell rating. Shares of the company are currently trading at $39 per share and are expected to fall to a price target of $36 per share. The price target is based on the CY2012E price-to-earnings ratio of 14.6x. Equifax is expected to generate an estimated return on capital of 10%. The price target was recently revised by Goldman Sachs taking into account improved operating results and recent multiple expansions for Equifax. Eminence Capital had the largest stake in EFX among the 350 hedge funds we are tracking.

Pitney Bowes, Inc. (PBI) provides mail processing equipment and integrated mail solutions on a global basis. It has been given a sell rating by Goldman Sachs. The company is currently facing protracted weakness in the SMB sector which could limit its valuation in the near future. Earnings growth is also reporting a slowdown but its consistent dividend yield of 8% will provide some support to the stock prices. Shares of the company are currently trading at $19.3 per share and are expected to go south of $18 per share by the end of 2012. Ray Dalio’s Bridgewater Associates sold its entire position in the company during the third quarter.

Solera Holdings, Inc. (SLH) provides software and services to the automobile insurance claims processing industry. It has been given a sell rating by Goldman Sachs. Solera Holdings has a significant exposure to the European markets in the near-term. Goldman Sachs recently lowered the price target for the company due to headwinds caused by an increase in financial expenditures. Its shares are currently trading at $43 per share and are expected to reach a price target of $41 per share. The company has a price-to-earnings ratio of 19.3x. Jim Simons’ Renaissance Technologies reduced its position in Solera by 11% during the third quarter.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!